These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1926450)

  • 1. Effects of substitutive triiodothyronine therapy on intracellular nucleotide levels in donor organs.
    García-Fages LC; Antolín M; Cabrer C; Talbot R; Alcaraz A; Lozano F; Manyalich M
    Transplant Proc; 1991 Oct; 23(5):2495-6. PubMed ID: 1926450
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic and metabolic effects of substitutive triiodothyronine therapy in organ donors.
    García-Fages LC; Cabrer C; Valero R; Manyalich M
    Transplant Proc; 1993 Dec; 25(6):3038-9. PubMed ID: 8266444
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration.
    Pérez-Blanco A; Caturla-Such J; Cánovas-Robles J; Sanchez-Payá J
    Intensive Care Med; 2005 Jul; 31(7):943-8. PubMed ID: 15937679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic status of brain-dead patients managed for organ procurement.
    Sztark F; Thicoïpe M; Masson F; Lassié P; Favarel-Garrigues JF; Petit-Jean ME
    Transplant Proc; 1993 Dec; 25(6):3171-2. PubMed ID: 8266504
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroid hormone levels in heart and kidney cadaver donors.
    Gifford RR; Weaver AS; Burg JE; Romano PJ; Demers LM; Pennock JL
    J Heart Transplant; 1986; 5(3):249-53. PubMed ID: 3302171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triiodothyronine replacement, the euthyroid sick syndrome, and organ transplantation.
    Novitzky D
    Transplant Proc; 1991 Oct; 23(5):2460-2. PubMed ID: 1926432
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive pharmacologic donor management results in more transplanted organs.
    Rosendale JD; Kauffman HM; McBride MA; Chabalewski FL; Zaroff JG; Garrity ER; Delmonico FL; Rosengard BR
    Transplantation; 2003 Feb; 75(4):482-7. PubMed ID: 12605114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool.
    Jeevanandam V; Todd B; Hellman S; Eldridge C; McClurken J; Addonizio VP
    Transplant Proc; 1993 Dec; 25(6):3305-6. PubMed ID: 8266553
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of hormonal therapy in improving organ viability in the transplant donor.
    Novitzky D; Cooper DK; Reichart B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2037-8. PubMed ID: 3079070
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart transplantation, euthyroid sick syndrome, and triiodothyronine replacement.
    Novitzky D
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S196-8. PubMed ID: 1515440
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of nucleotides, nucleosides, and oxypurines in human donor kidneys.
    Maessen JG; Van der Vusse GJ; Vork M; Kootstra G
    Transplant Proc; 1988 Oct; 20(5):889-90. PubMed ID: 3055525
    [No Abstract]   [Full Text] [Related]  

  • 12. Triiodothyronine therapy for heart donor and recipient.
    Novitzky D; Cooper DK; Human PA; Reichart B; Zuhdi N
    J Heart Transplant; 1988; 7(5):370-6. PubMed ID: 3058907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal therapy in the brain-dead experimental animal.
    Cooper DK; Novitzky D; Wicomb WN
    Transplant Proc; 1988 Oct; 20(5 Suppl 7):51-4. PubMed ID: 3055559
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies.
    Novitzky D; Cooper DK; Rosendale JD; Kauffman HM
    Transplantation; 2006 Dec; 82(11):1396-401. PubMed ID: 17164704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal resuscitation yields more transplanted hearts, with improved early function.
    Rosendale JD; Kauffman HM; McBride MA; Chabalewski FL; Zaroff JG; Garrity ER; Delmonico FL; Rosengard BR
    Transplantation; 2003 Apr; 75(8):1336-41. PubMed ID: 12717226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New profile of cadaveric donors: what are the kidney donor limits?
    Light JA; Kowalski AE; Ritchie WO; Gage F; Sasaki TM; Aquino A; Callender CO
    Transplant Proc; 1996 Feb; 28(1):17-20. PubMed ID: 8644161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Brain death and management of the donor with a view to organ transplantation].
    Geslin N
    Soins; 1982 Aug; (387-388):25-8. PubMed ID: 6755717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Removal of donor organs. Unresolved statutory problems].
    Grèzes-Rueff C; Arbus L; Campan L
    Med Leg Dommage Corpor; 1971; 4(3):242-4. PubMed ID: 5172459
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of hormonal therapy in human brain-dead potential organ donors.
    Novitzky D; Cooper DK
    Transplant Proc; 1988 Oct; 20(5 Suppl 7):59-62. PubMed ID: 3055561
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors.
    Novitzky D; Cooper DK; Reichart B
    Transplantation; 1987 Jun; 43(6):852-4. PubMed ID: 3296351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.